Abstract
Decision aids (DAs) are evidence-based tools that support shared decision-making (SDM) implementation in practice; this study aimed to identify existing osteoporosis DAs and assess their quality and efficacy; and to gain feedback from a patient advisory group on findings and implications for further research. We searched multiple bibliographic databases to identify research studies from 2000 to 2019 and undertook an environmental scan (search conducted February 2019, repeated in March 2020). A pair of reviewers, working independently selected studies for inclusion, extracted data, evaluated each trial’s risk of bias, and conducted DA quality assessment using the International Patient Decision Aid Standards (IPDAS). Public contributors (patients and caregivers with experience of osteoporosis and fragility fractures) participated in discussion groups to review a sample of DAs, express preferences for a new DA, and discuss plans for development of a new DA. We identified 6 studies, with high or unclear risk of bias. Across included studies, use of an osteoporosis DA was reported to result in reduced decisional conflict compared with baseline, increased SDM, and increased accuracy of patients’ perceived fracture risk compared with controls. Eleven DAs were identified, of which none met the full set of IPDAS criteria for certification for minimization of bias. Public contributors expressed preferences for encounter DAs that are individualized to patients’ own needs and risk. Using a systematic review and environmental scan, we identified 11 decision aids to inform patient decisions about osteoporosis treatment and 6 studies evaluating their effectiveness. Use of decision aids increased accuracy of risk perception and shared decision-making but the decision aids themselves fail to comprehensively meet international quality standards and patient needs, underpinning the need for new DA development.
Similar content being viewed by others
References
International Osteoporosis Foundation (2018) Broken bones, broken lives: a roadmap to solve the fragility fracture crisis in the United Kingdom. http://share.iofbonehealth.org/EU-6-Material/Reports/IOF_report_UK.pdf. Accessed 23 Dec 2019
van der Velde RY, Wyers CE, Teesselink E, Geusens PPMM, van den Bergh JPW, de Vries F, Cooper C, Harvey NC, van Staa TP (2017) Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: Variation by age, sex, geographic location and ethnicity. Bone 94:50–55. https://doi.org/10.1016/j.bone.2016.10.013
Hall SF, Edmonds SW, Lou Y, Cram P, Roblin DW, Saag KG, Wright NC, Jones MP, Wolinsky FD (2017) Patient-reported reasons for nonadherence to recommended osteoporosis pharmacotherapy. J Am Pharm Assoc 57:503–509. https://doi.org/10.1016/j.japh.2017.05.003
Cramer JA, Gold DT, Silverman SL, Lewiecki EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18:1023–1031
McHorney CA, Schousboe JT, Cline RR, Weiss TW (2007) The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates. Curr Med Res Opin 23:3137–3152
Salter C, McDaid L, Bhattacharya D, Holland R, Marshall T, Howe A (2014) Abandoned Acid? Understanding adherence to bisphosphonate medications for the prevention of osteoporosis among older women: A qualitative longitudinal study. PLoS One 9:e83552. https://doi.org/10.1371/journal.pone.0083552
Khosla S, Shane E (2016) A crisis in the treatment of osteoporosis. J Bone Miner Res 31:1485–1487
Paskins Z, Jinks C, Mahmood W, Jayakumar P, Sangan CB, Belcher J, Gwilym S (2017) Public priorities for osteoporosis and fracture research: results from a general population survey. Arch Osteoporos 12:45. https://doi.org/10.1007/s11657-017-0340-5
Stacey D, Légaré F, Lewis K, Barry MJ, Bennett CL, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, Trevena L (2017) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 12:CD001431. https://doi.org/10.1002/14651858.CD001431.pub5
Elwyn G, Frosch D, Volandes AE, Edwards A, Montori VM (2010) Investing in deliberation: a definition and classification of decision support interventions for people facing difficult health decisions. Med Decis Mak 30:701–711. https://doi.org/10.1177/0272989X10386231
National Institute for Health and Care Excellence (NICE) (2012) Patient experience in adult NHS services: improving the experience of care for people using adult NHS services. CG138. https://www.nice.org.uk/guidance/cg138. Accessed 23 Dec 2019
Joseph-Williams N, Newcombe R, Politi M, Durand MA, Sivell S, Stacey D, O’Connor A, Volk RJ, Edwards A, Bennett C, Pignone M, Thomson R, Elwyn G (2014) Toward minimum standards for certifying patient decision aids: a modified delphi consensus process. Med Decis Mak 34:699–710. https://doi.org/10.1177/0272989X13501721
Vaisson G, Provencher T, Dugas M, Trottier M-E, Chipenda-Dansokho S, Colquhoun H, Fagerlin A, Giguere A, Hakim H, Haslett L, Hoffman A, Ivers N, Julien A-S, Legare F, Renaud J-S, Stacey D, Volk R, Witteman H (2019) User involvement in the development of patient decision aids: a systematic review. https://doi.org/10.31219/OSF.IO/QYFKP
Torres-Roldan V, Urtecho LM, Espinoza N, Organick P, Thota A, Brito JP (2019) A systematic review and environmental scan of decision aids for osteoporosis: a review protocol. In: PROSPERO 2019 CRD42019126787. https://www.crd.york.ac.uk/prospero/display_record.php?ID = CRD42019126787. Accessed 23 Dec 2019
Donnelly KZ, Thompson R (2015) Medical versus surgical methods of early abortion: protocol for a systematic review and environmental scan of patient decision aids. BMJ Open 5:e007966. https://doi.org/10.1136/bmjopen-2015-007966
Graham P, Evitts T, Thomas-MacLean R (2008) Environmental scans: how useful are they for primary care research? Can Fam Physician 54:1022–1023
Doria N, Condran B, Boulos L, Curtis Maillet DG, Dowling L, Levy A (2018) Sharpening the focus: differentiating between focus groups for patient engagement vs. qualitative research. Res Involv Engagem 4:19
Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, Altman DG, Moher D, Barber R, Denegri S, Entwistle A, Littlejohns P, Morris C, Suleman R, Thomas V, Tysall C (2017) GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ 358:j3453. https://doi.org/10.1136/bmj.j3453
Cranney A, O’Connor AM, Jacobsen MJ, Tugwell P, Adachi JD, Ooi DS, Waldegger L, Goldstein R, Wells GA (2002) Development and pilot testing of a decision aid for postmenopausal women with osteoporosis. Patient Educ Couns 47:245–255. https://doi.org/10.1016/S0738-3991(01)00218-X
Cranney A, Simon LS, Tugwell P, Adachi R, Guyatt G (2009) Postmenopausal osteoporosis. In: Tugwell P, Shea B, Boers M, Brooks P, Simon L, Strand V, Wells G (eds) Evidence-based rheumatology. BMJ Books, pp 183–242
Watts NB, Manson JAE (2017) Osteoporosis and fracture risk evaluation and management: shared decision making in clinical practice. J Am Med Assoc 317:253–254. https://doi.org/10.1001/jama.2016.19087
Kunneman M, Branda ME, Hargraves I, Pieterse AH, Montori VM (2018) Fostering choice awareness for shared decision making: a secondary analysis of video-recorded clinical encounters. Mayo Clin Proc Innov Qual Outcomes 2:60–68. https://doi.org/10.1016/j.mayocpiqo.2017.12.002
Paskins Z, Worrall A, Chapman S (2018) Patient and public views of bisphosphonate decision aids: Not fit for purpose. In: Osteoporosis International. pp S374–S374
Lopez-Olivo MA, des Bordes JKA, Lin H, Rizvi T, Volk RJ, Suarez-Almazor ME (2019) Comparison of multimedia and printed patient education tools for patients with osteoporosis: a 6-month randomized controlled trial. Osteoporos Int. https://doi.org/10.1007/s00198-019-05210-4
Lopez-Olivo MA, Ingleshwar A, Volk RJ, Jibaja-Weiss M, Barbo A, Saag K, Leong A, Suarez-Almazor ME (2018) Development and pilot testing of multimedia patient education tools for patients with knee osteoarthritis, osteoporosis, and rheumatoid arthritis. Arthritis Care Res 70:213–220. https://doi.org/10.1002/acr.23271
Oakley S, Walley T (2006) A pilot study assessing the effectiveness of a decision aid on patient adherence with oral bisphosphonate medication. Pharm J 276:536–538
Pencille LJ, Campbell ME, Van Houten HK, Shah ND, Mullan RJ, Swiglo BA, Breslin M, Kesman RL, Tulledge-Scheitel SM, Jaeger TM, Johnson RE, Bartel GA, Wermers RA, Melton LJ, Montori VM (2009) Protocol for the osteoporosis choice trial. A pilot randomized trial of a decision aid in primary care practice. Trials 10:113. https://doi.org/10.1186/1745-6215-10-113
Montori VM, Shah ND, Pencille LJ, Branda ME, Van Houten HK, Swiglo BA, Kesman RL, Tulledge-Scheitel SM, Jaeger TM, Johnson RE, Bartel GA, Melton LJ, Wermers RA (2011) Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. Am J Med 124:549–556. https://doi.org/10.1016/j.amjmed.2011.01.013
Scoville EA, de Leon Lovaton PP, Shah ND, Pencille LJ, Montori VM (2011) Why do women reject bisphosphonates for osteoporosis? a videographic study. PLoS One 6:e18468. https://doi.org/10.1371/journal.pone.0018468
Coylewright M, Branda M, Inselman JW, Shah N, Hess E, LeBlanc A, Montori VM, Ting HH (2014) Impact of sociodemographic patient characteristics on the efficacy of decision aids a patient-level meta-analysis of 7 randomized trials. Circ Cardiovasc Qual Outcomes 7:360–367. https://doi.org/10.1161/HCQ.0000000000000006
LeBlanc A, Wang AT, Wyatt K, Branda ME, Shah ND, Van Houten H, Pencille L, Wermers R, Montori VM (2015) Encounter decision aid vs. clinical decision support or usual care to support patient-centered treatment decisions in osteoporosis: the osteoporosis choice randomized trial II. PLoS One 10. https://doi.org/10.1371/journal.pone.0128063
Hiligsmann M, Ronda G, van der Weijden T, Boonen A (2016) The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis. Osteoporos Int 27:2489–2496. https://doi.org/10.1007/s00198-016-3555-1
Smallwood AJ, Schapira MM, Fedders M, Neuner JM (2017) A pilot randomized controlled trial of a decision aid with tailored fracture risk tool delivered via a patient portal. Osteoporos Int 28:567–576. https://doi.org/10.1007/s00198-016-3767-4
Montori VM, Kunneman M, Brito JP (2017) Shared decision making and improving health care the answer is not in. JAMA 15:617. https://doi.org/10.1001/jama.2017.10289
Van de Velde S, Heselmans A, Delvaux N, Brandt L, Marco-Ruiz L, Spitaels D, Cloetens H, Kortteisto T, Roshanov P, Kunnamo I, Aertgeerts B, Vandvik PO, Flottorp S (2018) A systematic review of trials evaluating success factors of interventions with computerised clinical decision support. Implement Sci 13:114
Scalia P, Durand MA, Berkowitz JL, Ramesh NP, Faber MJ, Kremer JAM, Elwyn G (2019) The impact and utility of encounter patient decision aids: systematic review, meta-analysis and narrative synthesis. Patient Educ Couns 102:817–841
Public Involvement Standards Development Partnership (2019) National Standards for Public Involvement in Research
Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, Van Der Weijden T (2013) A systematic development process for patient decision aids. BMC Med Inform Decis Mak 13:S2. https://doi.org/10.1186/1472-6947-13-S2-S2
Raybould G, Babatunde O, Evans AL, Jordan JL, Paskins Z (2018) Expressed information needs of patients with osteoporosis and/or fragility fractures: a systematic review. Arch Osteoporos 13:1–16. https://doi.org/10.1007/s11657-018-0470-4
Stacey D, Suwalska V, Boland L, Lewis KB, Presseau J, Thomson R (2019) Are patient decision aids used in clinical practice after rigorous evaluation? A survey of trial authors. Med Decis Mak 39:805–815. https://doi.org/10.1177/0272989X19868193
Funding
ZP is funded by the National Institute for Health Research (NIHR), Clinician Scientist Award (CS-2018-18-ST2-010)/NIHR Academy. AH is a NIHR funded Academic Clinical Fellow. CJ is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Juan P Brito, Victor D Torres Roldan, Meritxell Urtecho S, Nataly R. Espinoza Suarez, and Lisdamys Morera work at the Knowledge and Evaluation Unit at the Mayo Clinic where the Osteoporosis Choice tool was developed. Zoe Paskins, Ashley W Hawarden, Laurna Bullock, Gabriel F Torres, Anne Worrall, Steven Blackburn, Stephen Chapman, and Clare Jinks declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Consent to participate
This article does not contain any studies with human participants or animals performed by any of the authors.
Consent for publication
This article does not contain any studies with human participants or animals performed by any of the authors.
Disclaimer
The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health and Social Care.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
ZP and VTR are joint first author
Electronic supplementary material
ESM 1
(DOCX 121 kb)
Rights and permissions
About this article
Cite this article
Paskins, Z., Torres Roldan, V.D., Hawarden, A.W. et al. Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan. Osteoporos Int 31, 1837–1851 (2020). https://doi.org/10.1007/s00198-020-05479-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-020-05479-w